FierceBiotech

FDA Approves Cialis (tadalafil) for Once Daily Use for the Treatment of Erectile Dysfunction

INDIANAPOLIS, Jan 08, 2008 -- Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved Cialis® (tadalafil)(1) for once daily use (2.5 mg and 5 ...
FierceBiotech

FDA Approves Addition to CIALIS® (tadalafil) Product Label

Study Data Shows Cialis 5 mg Initiated with Finasteride Provides Significantly Greater Improvements in Urinary Symptoms of Benign Prostatic Hyperplasia than Placebo with Finasteride INDIANAPOLIS, Oct.
FiercePharma

European Commission approves Cialis® (tadalafil) tablets for the treatment of the signs and symptoms of benign prostatic hyperplasia

Cialis becomes only medication approved in the EU for both erectile dysfunction and signs and symptoms of benign prostatic hyperplasia INDIANAPOLIS, Oct. 30, 2012 /PRNewswire/ -- Eli Lilly and Company ...
FiercePharma

Pivotal Phase III Study Met its Co-Primary Endpoints

INDIANAPOLIS, Oct. 12, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that a pivotal Phase III study of Cialis® (tadalafil) tablets 5 mg for once daily use met its co-primary ...
Medindia

Cialis® (tadalafil) marks 10 years since U.S. approval

Cialis is turning 10. As Cialis marks its 10 th anniversary this week, Lilly is looking back on the last decade in men's health. "Witnessing the evolution of Cialis since it entered the market 10 ...